HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

vanadium(III)-cysteine

a chemoprotectant that consists of three cysteines in complex with V(III) ion; structure in first source

Also Known As:

vanadium(III)-L-cysteine

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Baral, Rathindranath: 1 article (05/2017)
2.	Basu, Abhishek: 1 article (05/2017)
3.	Bhattacharjee, Arin: 1 article (05/2017)
4.	Bhattacharya, Sudin: 1 article (05/2017)
5.	Biswas, Jaydip: 1 article (05/2017)
6.	Samanta, Amalesh: 1 article (05/2017)

Related Diseases

1.	Body Weight (Weight, Body) 05/01/2017 - "In this study, vanadium(III)-l-cysteine (1 mg/kg body weight, per os) was administered alone as well as in combination with cyclophosphamide (25 mg/kg body weight, intraperitoneal) in concomitant and pretreatment schedule in mice bearing breast adenocarcinoma cells. "
2.	Adenocarcinoma 05/01/2017 - "Vanadium(III)-l-cysteine enhances the sensitivity of murine breast adenocarcinoma cells to cyclophosphamide by promoting apoptosis and blocking angiogenesis." 05/01/2017 - "In this study, vanadium(III)-l-cysteine (1 mg/kg body weight, per os) was administered alone as well as in combination with cyclophosphamide (25 mg/kg body weight, intraperitoneal) in concomitant and pretreatment schedule in mice bearing breast adenocarcinoma cells. "
3.	Neoplasms (Cancer) 05/01/2017 - "Administration of vanadium(III)-l-cysteine also resulted in significant attenuation of peritoneal vasculature and sprouting of the blood vessels by decreasing the levels of vascular endothelial growth factor A and matrix metalloproteinase 9 in the ascites fluid of tumor-bearing mice. "
4.	Ascites 05/01/2017 - "Administration of vanadium(III)-l-cysteine also resulted in significant attenuation of peritoneal vasculature and sprouting of the blood vessels by decreasing the levels of vascular endothelial growth factor A and matrix metalloproteinase 9 in the ascites fluid of tumor-bearing mice. "

Related Drugs and Biologics

1.	Cyclophosphamide (Cytoxan)
2.	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
3.	Matrix Metalloproteinase 9 (Gelatinase B)